GEODE CAPITAL MANAGEMENT, LLC - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 36 filers reported holding OCUPHIRE PHARMA INC in Q4 2022. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$734,212
-12.8%
219,113
+12.9%
0.00%
Q2 2023$842,172
+23.8%
194,049
+7.0%
0.00%
Q1 2023$680,137
+111397.9%
181,370
+4.8%
0.00%
Q4 2022$610
-99.8%
173,067
+14.2%
0.00%
Q3 2022$304,000
+7.4%
151,569
+2.8%
0.00%
Q2 2022$283,000
-32.6%
147,459
+13.5%
0.00%
Q1 2022$420,000
+23.9%
129,924
+42.7%
0.00%
Q4 2021$339,000
-16.5%
91,068
+15.4%
0.00%
Q3 2021$406,000
+200.7%
78,923
+208.4%
0.00%
Q2 2021$135,000
+107.7%
25,594
+126.5%
0.00%
Q1 2021$65,00011,3000.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 368,003$1,232,8122.32%
Knoll Capital Management, LLC 100,000$335,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 828,628$2,775,9040.18%
Diametric Capital, LP 56,059$187,7970.08%
THOMPSON DAVIS & CO., INC. 17,000$56,9500.07%
MAI Capital Management 455,677$1,526,5180.02%
TRUST CO OF TOLEDO NA /OH/ 30,963$103,7260.02%
BEDEL FINANCIAL CONSULTING INC 15,000$50,2500.01%
Legato Capital Management LLC 10,098$33,8280.01%
Stokes Family Office, LLC 13,030$43,6510.01%
View complete list of OCUPHIRE PHARMA INC shareholders